# BioMark Diagnostics Inc. (BMKDF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BMKDF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 59.8K | $ -1.48M | $ -1.09M | $ 724.9K | $ 331.1K |
| 2025 | $ 154.2K | $ -1.93M | $ -1.10M | $ 454.2K | $ 1.74M |
| 2024 | $ 166.3K | $ -1.45M | $ -1.01M | $ 1.55M | $ -609.6K |
| 2023 | $ 159.3K | $ -1.91M | $ -954.3K | $ 1.65M | $ -1.15M |
| 2022 | $ 47.1K | $ -1.56M | $ -1.36M | $ 1.05M | $ -635.7K |
| 2021 | $ 0 | $ -1.25M | $ -519.6K | N/A | $ -79.1K |
| 2020 | $ 314.7K | $ -1.45M | $ -543.4K | N/A | $ -439.1K |
| 2019 | $ 0 | $ -678.4K | $ -334.6K | N/A | $ -1.22M |
| 2018 | $ 0 | $ -894.8K | $ -950.6K | N/A | $ -900.4K |
| 2017 | $ 0 | $ -898.4K | $ -399.0K | N/A | $ -1.07M |
| 2016 | $ 0 | $ -1.79M | $ -843.6K | N/A | $ -554.3K |
| 2015 | $ 0 | $ -3.73M | $ -1.53M | $ 0 | $ 148.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.19 |
| Liabilities / Eq | 4.62 |
| Current Ratio | 0.99 |

## Other views

- [Metrics](https://sponda.capital/en/BMKDF.md)
- [Charts](https://sponda.capital/en/BMKDF/charts.md)
- [Compare](https://sponda.capital/en/BMKDF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.